Security key
90466Y103
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)
CUSIP: 90466Y103
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 18,578,488
- Total 13F shares
- 795,253
- Share change
- -172,949
- Total reported value
- $428,290
- Price per share
- $0.54
- Number of holders
- 9
- Value change
- -$100,167
- Number of buys
- 3
- Number of sells
- 7
Report period
Q4 2022
Institutions
9
Top holders
9
UNCY full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Unicycive Therapeutics, Inc. SEC filings
Unicycive Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 90466Y103
Recent filing periods:
Top shareholders of UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13F
|
Company |
3.8%
|
710,542
|
$419,000 | — | 30 Sep 2022 | |
| Ayrton Capital LLC |
13F
|
Company |
0.41%
|
76,645
|
$45,000 | — | 30 Sep 2022 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
0.34%
|
63,019
|
$37,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
26,109
|
$15,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.12%
|
22,695
|
$13,000 | — | 30 Sep 2022 | |
| CAPTRUST FINANCIAL ADVISORS |
13F
|
Company |
0.1%
|
18,800
|
$11,000 | — | 30 Sep 2022 | |
| FineMark National Bank & Trust |
13F
|
Company |
0.08%
|
15,625
|
$9,000 | — | 30 Sep 2022 | |
| TANDEM CAPITAL MANAGEMENT CORP /ADV |
13F
|
Company |
0.08%
|
15,500
|
$10,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.07%
|
12,900
|
$8,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
5,177
|
$3,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,190
|
$1,000 | — | 30 Sep 2022 | |
| Brigitte Schiller |
3/4/5
|
Director |
—
class O/S missing
|
41,738
|
— | — | 15 Jul 2022 |
Institutional Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q4 2022
As of 31 Dec 2022,
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
795,253 shares.
The largest 9 holders included
Nantahala Capital Management, LLC, Board of Trustees of The Leland Stanford Junior University, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, TANDEM CAPITAL MANAGEMENT CORP /ADV, Virtu Financial LLC, Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, and BANK OF AMERICA CORP /DE/.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
11
Q4 2022 holders
9
Holder diff
-2
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.